Fundraising Fox

Telomir Pharmaceuticals

NASDAQ: TELO

Tampa, US · Founded 2021 · Florida corporation · 1 known investors

Biotech

Founders & leadership

JM
James McNultyinTreasurer, Chief Financial Officer and Secretary
CC
Chris ChapmaninPresident, Chief Executive Officer and Chairman

Board

TT
Tuck TalhiaBoard director
CE
Craig EagleBoard director
DV
David VorhoffBoard director
HM
Hugh McCollBoard director
JU
Jude UzonwanneBoard director

Investors · 1

Also in the syndicate · 1

The Starwood Trust

Funding

SEC filings, press & company announcements

$2M disclosed across 2 rounds · 2023–2024

  • $1MraisedDec 2024 · 3 sources

    The Starwood Trust

    Source ↗
▶$1MraisedApr 2023 · 10 investors · Pharmaceuticals
Rule 506(b)
Officers, directors & promoters on the filing
  • Tuck TalhiaDirector
  • Craig EagleDirector
  • David VorhoffDirector
  • James McNultyExecutive Officer
  • Chris ChapmanExecutive Officer, Director
  • Hugh McCollDirector
  • Jude UzonwanneDirector
Offering amount
$1M
Amount sold
$1M
Sales commissions
$90K
Placement agents
Skyway Capital Markets, LLC
First sale
Mar 2023
Incorporated
Corporation, Florida, 2021
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

In the news

Telomir Q1 loss, cash strain and TELI merger detailed | TELO Quarterly Report (10-Q)stocktitan.net · May 2026Telomir Pharmaceuticals, Inc. Auditor Raises 'Going Concern' Doubt | MarketScreenermarketscreener.com · Mar 2026Telomir-1 shows promise in reactivating tumor suppressor genes By Investing.cominvesting.com · Oct 2025Telomir Pharmaceuticals Raises $1 Million at $7 per Share in a No-Warrant, Restricted Common Stock Deal, Representing a 20% Premium to Closing Price - BioSpacebiospace.com · Dec 2024Telomir Pharmaceuticals Secures Premium-Priced Funding After Breakthrough Anti-Aging Drug Results | TELO Stock Newsstocktitan.net · Dec 2024Telomir Pharmaceuticals Raises $1 Million at $7 per Share in a No-Warrant, Restricted Common Stock Deal, Representing a 20% Premium to Closing Pricefinance.yahoo.com · Dec 2024

Frequently asked questions

How much funding has Telomir Pharmaceuticals raised?
Telomir Pharmaceuticals has disclosed $2M raised across 2 rounds.
Where is Telomir Pharmaceuticals headquartered?
Telomir Pharmaceuticals is headquartered in Tampa, US.